Where can I buy CDXS shares?
Shares of CDXS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
What will Codexis'stock price be worth in the next year?
5 brokers have issued 1 year price objectives for Codexis' shares. Their forecasts range from $30.00 to $38.00. On average, they expect Codexis' stock price to reach $32.80 in the next year. This suggests a possible upside of 27.4% from the stock's current price.
Who is Codexis'(CDXS) CEO?
For example, Codexis ( NASDAQ:CDXS... With me today are John Nicols, Codexis' President and Chief Executive Officer; and Ross Taylor, Codexis' Chief Financial Officer.
Is Cdxs a buy?
Codexis Inc (NASDAQ:CDXS) The 8 analysts offering 12-month price forecasts for Codexis Inc have a median target of 21.50, with a high estimate of 39.00 and a low estimate of 18.00. The median estimate represents a +215.71% increase from the last price of 6.81.
Is codexis a public company?
02, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced the pricing of an underwritten public offering of 4,285,715 shares of its common stock at a public offering price of $17.50 per share.
What does Codexis do?
What does Codexis do? Codexis Inc. is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover and develop novel, high performance enzymes and novel biotherapeutics.
Is CDXS stock a buy right now?
5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Codexis in the last year. There are currently 5 buy ratings for t...
Will Codexis' stock price go up in 2022?
5 analysts have issued 12 month price objectives for Codexis' shares. Their forecasts range from $30.00 to $39.00. On average, they anticipate Code...
How has Codexis' stock price performed in 2022?
Codexis' stock was trading at $31.27 on January 1st, 2022. Since then, CDXS stock has decreased by 67.0% and is now trading at $10.31. View the be...
When is Codexis' next earnings date?
Codexis is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022. View our earnings forecast for Codexis .
How were Codexis' earnings last quarter?
Codexis, Inc. (NASDAQ:CDXS) issued its earnings results on Thursday, May, 5th. The biotechnology company reported ($0.13) earnings per share (EPS)...
What guidance has Codexis issued on next quarter's earnings?
Codexis updated its FY 2022 earnings guidance on Monday, June, 6th. The company provided earnings per share guidance of for the period. The company...
Who are Codexis' key executives?
Codexis' management team includes the following people: Mr. John J. Nicols , Pres, CEO & Director (Age 58, Pay $1.17M) ( LinkedIn Profile ) Mr....
What is John J. Nicols' approval rating as Codexis' CEO?
25 employees have rated Codexis CEO John J. Nicols on Glassdoor.com . John J. Nicols has an approval rating of 68% among Codexis' employees.
Who are some of Codexis' key competitors?
Some companies that are related to Codexis include Amgen (AMGN) , Gilead Sciences (GILD) , Vertex Pharmaceuticals (VRTX) , Regeneron Pharmaceut...
When is Codexis earnings call?
How much does Codexis make?
How can I listen to Codexis' earnings call? Codexis will be holding an earnings conference call on Thursday, August 5th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 201-612-7415 with passcode "13721066".
Nasdaq Global Select
How much money does Codexis make? Codexis has a market capitalization of $1.31 billion and generates $69.06 million in revenue each year . The biotechnology company earns $-24,010,000.00 in net income (profit) each year or ($0.40) on an earnings per share basis.
Environmental, Social, and Governance Rating
Codexis is a biotech company trying to turn cellulosic biomass into fuel. It was spun off from Maxygen in 2010.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
How much is Codexis stock worth in 2021?
Codexis is a biotech company trying to turn cellulosic biomass into fuel. It was spun off from Maxygen in 2010.
Does Codexis have a sell signal?
The Codexis stock price gained 3.22% on the last trading day (Friday, 9th Jul 2021), rising from $21.71 to $22.41. , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 4.10% from a day low at $21.71 to a day high of $22.60. The price has risen in 6 of the last 10 days and is up by 0.36% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 41 thousand more shares were traded than the day before. In total, 321 thousand shares were bought and sold for approximately $7.20 million.
What is Codexis Inc?
The Codexis stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance ...
Does market cap include convertible securities?
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products. The firm's products and services include Screening and Evolution services, Enzymes, Screening Kits. It also develops protein engineering and biocatalyst platforms such as Codeevolver, Ketoreductases, Transminases, Imine reductases, etc. The company operates in two business segments namely Performance Enzymes
